Current Search Criteria: Intervention: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel
Found 40 matching trials
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer PHASE2 This multi-center, open-label, phase II randomized controlled trial is to e...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer PHASE2 This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Show More Location
Multiple Locations
Learn More & Join Trial
To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer PHASE2 This study will evaluate the efficacy and safety of treatment with oral cap...
Show More Location
Multiple Locations
Learn More & Join Trial
Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer PHASE3 To evaluate the benefit of adding docetaxel-5 fluorouracile (D-5FU) regimen...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer PHASE3 In this trial investigators propose to assess the dose dense, G-CSF support...
Show More Location
University Hospital of Crete
Learn More & Join Trial
Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer PHASE3 Anthracycline-containing regimens are recommended as adjuvant treatment for...
Show More Location
University Hospital of Crete
Learn More & Join Trial
The Synergism Or Long Duration (SOLD) Study PHASE3 The purpose of the study is to compare disease-free survival (DFS) of women...
Show More Location
Helsinki University Central Hospital, Department of Oncology
Learn More & Join Trial
Breast Cancer Treated by Neoadjuvant Chemotherapy PHASE2 Neoadjuvant chemotherapy, known as "first" or "induction chemotherapy" in t...
Show More Learn More & Join Trial
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer PHASE3 This trial will compare 6 versus 12 months of trastuzumab in combination wi...
Show More Location
University Hospital of Crete
Learn More & Join Trial